Peregrine Capital Management LLC Acquires 2,531 Shares of Phreesia, Inc. (NYSE:PHR)

Peregrine Capital Management LLC lifted its holdings in shares of Phreesia, Inc. (NYSE:PHR) by 0.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 319,327 shares of the company’s stock after buying an additional 2,531 shares during the quarter. Peregrine Capital Management LLC’s holdings in Phreesia were worth $8,034,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Venturi Wealth Management LLC bought a new stake in Phreesia during the fourth quarter valued at $76,000. Rhumbline Advisers boosted its position in shares of Phreesia by 7.4% during the 4th quarter. Rhumbline Advisers now owns 83,631 shares of the company’s stock valued at $2,104,000 after acquiring an additional 5,756 shares during the last quarter. R Squared Ltd purchased a new position in shares of Phreesia during the fourth quarter worth about $30,000. Wesbanco Bank Inc. increased its position in shares of Phreesia by 76.9% in the fourth quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock worth $1,157,000 after purchasing an additional 20,000 shares during the last quarter. Finally, Franklin Resources Inc. raised its stake in Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares in the last quarter. 92.10% of the stock is owned by institutional investors.

Phreesia Stock Performance

NYSE:PHR opened at $29.99 on Wednesday. The stock has a 50-day moving average price of $27.05 and a 200 day moving average price of $23.72. The stock has a market capitalization of $1.74 billion, a P/E ratio of -20.40 and a beta of 0.96. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. The business’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.58) EPS. Equities research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on PHR shares. Citigroup lifted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Piper Sandler reaffirmed an “overweight” rating and set a $33.00 price target (up previously from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and increased their price objective for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. KeyCorp raised their price objective on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Finally, JMP Securities reiterated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Thirteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $31.15.

Insider Activity

In other news, Director Michael Weintraub sold 15,152 shares of the firm’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $21.01, for a total value of $318,343.52. Following the completion of the sale, the director now owns 242,827 shares in the company, valued at approximately $5,101,795.27. This trade represents a 5.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Allison C. Hoffman sold 3,495 shares of the business’s stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $24.88, for a total value of $86,955.60. Following the transaction, the general counsel now owns 116,296 shares of the company’s stock, valued at $2,893,444.48. This trade represents a 2.92 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 223,553 shares of company stock worth $5,909,315. 5.80% of the stock is currently owned by corporate insiders.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.